Gentian is a company listed on Euronext Oslo Børs as GENT.
Latest share price development, trade volumes and other share information can be found on Euronext.
31.01.2023
Shareholder | No of Shares | % |
Vatne Equity AS | 2,110,224 | 13.68% |
Kvantia AS | 1,623,368 | 10.53% |
Holta Life Sciences AS | 1,214,702 | 7.88% |
Verdipapirfondet Delphi Nordic | 973,999 | 6.32% |
Safrino AS | 749,700 | 4.86% |
Skandinaviska Enskilda Banken AB | 495,882 | 3.22% |
Verdipapirfondet DNB SMB | 361,291 | 2.34% |
Salix AS | 357,735 | 2.32% |
Verdipapirfondet Storebrand Vekst | 336,483 | 2.18% |
J.P. Morgan SE | 325,000 | 2.11% |
Carpe Diem Afseth AS | 301,796 | 1.96% |
Portia AS | 300,000 | 1.95% |
Equinor Pensjon | 245,047 | 1.59% |
Cressida AS | 235,000 | 1.52% |
Krefting, Johan Henrik | 233,400 | 1.51% |
Verdipapirfondet Equinor Aksjer NO | 227,880 | 1.48% |
Lioness AS | 220,000 | 1.43% |
Marstal AS | 212,407 | 1.38% |
Mutus AS | 210,465 | 1.36% |
Vingulmork Predictor AS | 184,083 | 1.19% |
Other Shareholders | 4,503,888 | 29.20% |
Total Shares | 15,422,350 | 100.00% |
Name and position of primary insiders can be found on Euronext.
Njaal Kind
CFO, Gentian Diagnostics ASA
njaal.kind@gentian.com
+47 91906525